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Benzene-Mediated Protein Kinase C
Activation
By Corinne Da Silva,*Xiaotang Fan,* and
Monique Castagna*
Extracellular ligands transfer information into the cell through several pathways that operate in an in-
tegrated fashion. Protein kinase C, andenzyme thatplays apivotal role in signal transduction, is the molecu-
lartarget fortumorpromoters from the series ofphorbol esters. A number ofstructurally unrelated tumor
promoters also enhanceprotein kinase C, interacting or not interactingwith the phorbol esterbin-ding site.
Evidence is provided that benzene potently activate protein kinase C in vitro, as well as in intact platelets.
The drugdoes not compete forthephorbol esterbinding site andprobably affects the hydrophobic environ-
mentrequires forfull enzyme activation. Toluene is equally active. The relevance ofthe presented findings
in the carcinogenic effects ofbenzene is discussed.
Introduction
There is clinical as well as experimental evidence that
cancer is a multistep process that may involve several
causal agents. Two stages have been characterized from
the experimental model designed by Berenblum (1) and
Mottram (2) in mouse skin: initiation andpromotion. More
recently, models ofcultured cells have alsoprovided evi-
dence that cell transformation by physical and chemical
carcinogens requires at least two steps. The initial one is
a frequent event that gives rise to potentially trans-
formed cells or "initiated" cells, whereas the second one
is a rare event that may occureach time an initiated cell
divides (3). The requirement for two genetic events ap-
parently corroborates the result oftransfection experi-
ments that indicate that at least two cooperating on-
cogenes are needed to convert primary embryo
fibroblasts into tumor cells (4).
The two classes of carcinogenic agents can be distin-
guished on the basis oftheirmolecular targets. Initiators
include chemicals that affect DNA and elicit irreversible
effects as well as agents that generate genetic damage
(i.e., mutation, deletion, insertion, translocation or am-
plification) such as UV light, ionizing radiation, various
retroviruses and DNA-containing viruses. Promoters
evoke epigenetic changes and reversibly modify the cel-
lular phenotype, including chemicals as well as physical
agents causing chronic tissue injury.
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Tumor promoters are not carcinogenic by themselves
but increase the probability ofan initiator-treated cell to
become malignant. Despite their lack ofcarcinogenicity,
tumor promoters play a key role in the etiology of can-
cer. In fact, genotoxic carcinogens are generally present
at harmless doses in the environment and only become
nocive when associated withtumorpromoters, which dra-
matically lower a carcinogen's threshold of action (5).
Two findings have led to the indentification ofthe ma-
jormolecular target ofphorbol esters andhave shedlight
on the mechanism by which these potent tumor
promoters modify the cellularphenotype. First, Driedger
and Blumberg, using(3H)phorbol esters, were able to de-
tect high-affinity binding sites for phorbol esters in var-
ious cell lines (6). Second, as a result of a collaborative
work with Y. Nishizuka, we have contributed to the in-
dentification of protein kinase C, a phospholipid and
Ca2+-activated enzyme involved in signal transduction,
as the high-affinity binding site forphorbol esters (7-9).
In this presentation we wish to provide evidence that
protein kinase C is not an exclusive moleculartargetfor
phorbol ester tumorpromoterand that its enzyme activ-
ity may be affectedby benzene and various other tumor
promoters.
Protein Kinase C Activation by
Tumor-Promoting Phorbol Esters
Signal transduction from extracellularligands into the
cellfollows different strategies. The twobest known sig-
naling pathways are shown schematically in Figure 1.DA SILVA, FAN, AND CASTAGNA
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FIGURE 1. Model of cyclic AMP- and IP3/DG-mediated signaling path-
ways. Abbreviations: PKA, cyclic AMP-dependent protein kinase;
PKC, protein kinase C; PI-PDE, phosphatidylinositol phosphodiester-
ase; PI,phosphatidylinositol; PIP, phosphate dylinositol4-phosphate;
PIP2, phosphatidylinositol 4,5-bisphophate; IP3, inositol
1,4,5-trisphosphate; DG, diacylglycerol.
A number ofhormones and neurotransmitters gener-
ate cyclicAMP, which serves as a second messenger and
triggers protein phosphorylation through activation of a
cyclic AMP-dependent protein kinase, while two GTP-
bindingproteins negatively orpositively modulate the re-
sponse. Alternatively, alarge series ofligands that con-
trol growth and cellular functions, including neurotrans-
mitters, regulatorypeptides, hormones, releasingfactors,
platelet activators and gro% ;hfactors, proceedsthrough
mediation by two second messengers. Upon ligand-
receptor interaction, phosphatidylinositol 4,5-bisphos-
phate is hydrolyzed and two second messengers are
formed: diacylglycerol (DG) and inositol 1,4,5-trisphos-
phate (IP3). The signaling pathway divides into two
branches, the second messengers initiating two sets of
cellular events. The formermediatesprotein kinase C ac-
tivation, and the latter triggers Ca2 + mobilization from
internal stores and consequently raises cytosolic Ca2 + .
A GTP-binding protein functionally similar to those that
have been involved in the adenylate cyclase system
modulates signal transduction at this step. The two
branches act separatelybutboth seem toberequiredfor
full cellular response (8-11).
The two pathways may not be independent and fre-
quently affect each other. Cyclic AMP-mediated signals
negatively control the protein kinase C pathway. Con-
versely, IP3/DG-mediated signals block adenylate activ-
ity. Also, both series ofsignals potentiate each other in
various cell types or cell lines.
Tumor-promotingphorbol esters substitute forthe sec-
ond messenger DG in activating protein kinase C and
subsequently bypass the upper part of the pathway.
These agents compete with DG for its binding site and
display ahigher affinity than the natural effector. How-
ever, phorbol esters do not fully mimic physiological
stimuli. We have recently suggested that these ligands
triggerquantitatively andqualitatively differentprotein
kinase C response due to their specific properties which
differ in several respects (9): a) the half-life ofDG is less
than 1 min in platelets, whereas phorbol esters like TPA
are slowly metabolized in cells; b) phorbol esters do not
mobilize Ca2+ from internal stores; c)phorbol esters can
bypass some regulatory mechanisms that control the
IP3/DG pathway, as illustrated in platelets where cyclic
nucleotides inhibit thrombin-mediated and not phorbol
ester-mediated protein kinase C activation (12); and d)
phorbol esters can diffuse inall the cellularcompartments
and as a consequence may evoke a different localization
of protein kinase C compared to physiological ligands,
thus providing additional substrates to the enzyme. It is
likely that these distinctive features might account, at
least partly, for their promoting effects.
Benzene and Toluene-Mediated
Protein Kinase C Activation
Some reports have supported the possibility thatben-
zenemay act as atumorpromoterinitsneoplastic effects
(13). This prompted us-to investigate whether this com-
pound affected protein kinase C activity.
The first experiments were designed to test the
potency ofbenzene and its alkylated derivative toluene
on protein kinase C activity in intact platelets. In re-
sponse to physiological ligands, protein kinase C phos-
phorylates inplatelets a set ofspecificprotein substrates.
The preferential substrate ofthe enzyme is a 43 KDpro-
tein, which serves as an index ofprotein kinase C activ-
ity in these cells. Figure 2 shows the autoradiogram of
SDS-polyacrylamide gel electrophoresis ofplatelet pro-
teins afterthe cellswere exposedfor2 minto either 12-0-
tetradecanoylphorbol 13-acetate (TPA), benzene, or
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FIGURE 2. Autoradiogram of SDS-polyacrylamide gel electrophoresis
ofplatelet proteins. Cells were stimulated for 2 min with 100 ng/mL
TPA (lane a), 5 ML DMSO (lane b), 10% benzene (lanesc,e), 2% ben-
zene(lanesdf), 10% toluene (laneg), and 2% toluene(lane h). Reprint-
ed from Roghani et al. (14).
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Table 1. Toluene- and benzene-protein kinase C activity in vitro.
Addition, Enzyme activity, Increase,
v/v cpm/assaya %
None 3280 + 246 100
Toluene
0.8% 6432 + 407 196
2.4% 8859 + 520 270
4.8% 7993 + 399 243
Benzene
0.8% 5050 + 376 154
2.4% 7077 + 529 215
4.8% 7219 ± 415 220
aAssays were carried out in the presence of0.1 mM CaCl2. Data are
means + SE of three experiments in duplicate.
toluene. It canbe seen thatthe two latter compounds ac-
tivate 43 KD protein phosphorylation and give a phos-
phorylation pattern similarto that evokedby TPA, sug-
gestingthatthese phosphorylation events were mediated
by the same enzyme.
We have investigated the possibility that benzene in-
teracts with protein kinase C on the phorbol ester/DG
binding site. As aresult ofbinding studies conducted on
protein kinase C accordingto apreviously describedtech-
niqueusing 3H-TPA(15), wewere unable to showany sig-
nificant alteration of phorbol ester binding in the pres-
ence of either benzene or toluene (data not shown).
To further substantiate these findings, the action of
benzene and toluene was studied in the in vitro assay
described in Roghani et al. (14), using a preparation of
protein kinase C from mouse brain. Results show that
both chemicals directly activated protein kinase C in the
presence of phosphatidylserine and Ca2+ at concentra-
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tions below 1% (Table 1). The dose-response curve of
toluene-triggered protein kinase C activation in the pres-
ence of0.5 mM EGTA is shown in Figure 3. Upon addi-
tion ofTPA at 50 ng/mL, a slight stimulation could also
be detected. Benzene and toluene-mediated enzyme ac-
tivation wasnot dependent on Ca2 . It should bepointed
our that the omission of phospholipid in the incubation
mixture prevented enzyme activation, suggesting that
the two drugs might interfere with the enzyme-
phospholipid interaction.
We have recently shown that mixtures of sodium
deoxycholate and phosphatidylserine were much more
potent than phosphatidylserine alone in supportingpro-
teinkinase C activityandthat sodium deoxycholate alone
was an enzyme activator (manuscript in preparation).
Surprisingly, using such mixtures containing a ratio of
phosphatidylserine/deoxycholate of 1/9 (w/w), we could
not get any benzene-mediated enzyme activation. Fur-
thermore, benzene inhibited sodium deoxycholate-
mediatedprotein kinase C activation. Results displayed
in Figure 4 show the differential effects of benzene on
protein kinase C activation depending on the hydropho-
bic environment. The complexity ofthe reaction is even
more emphasized in experiments where benzene inhibi-
tion was studied as afunction ofdeoxycholate concentra-
tions, where at low concentrations of deoxycholate and
benzene, an activation of the enzyme can be detected
(Fig. 5). The results suggest that benzene and toluene
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FIGURE 3. Dose-response curve of toluene-mediated protein kinase C
activation in the presence of0.5 mM EGTA (o) or 0.5 mM EGTA +
50 ng/mL TPA (0). In some assays, phospholipid was omitted and
0.5 mM EGTA was added (U). Adapted from Roghani et al. (14).
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FIGURE 4. Differential effects ofbenzene on protein kinase C activity
in various hydrophobic environments. The enzyme was assayed in
0.5 mM EGTA essentially as described in Roghani et al. (14), in the
presence ofeither 80jg/mL phosphatidylserine (0), 80pg/mL mix-
ture ofphosphatidylserine/sodium deoxycholate in a ratio of 1/9(wlw)
(4), or 10jMg/mL sodium deoxycholate (A).
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FIGURE 5. Opposing effects ofbenzene on protein kinase C activity as
a function ofsodium deoxycholate concentrations. The enzyme was
assayed in 0.1 mM CaCk as described in Roghani et al. (14). Sodium
deoxycholate was added at the concentrations of2pg/mL(0), 5pg/mL
(4), or 10 pg/mL (U).
may participate in the hydrophobic environment that is
requiredformaximal enzyme activation. As pointed out
recently in several reports, the interaction between en-
zyme, phospholipid, and substrate is a complex one
(16,17). The present data suggest thatbile salts andben-
zene mayhelp to elucidate how ahydrophobic domain can
activate the enzyme.
Implication of Protein Kinase C in
Tumor Promotion
Is tumorpromotion associated withproteinkinase C ac-
tivation and more generally with aberrant signal trans-
duction? In order to explore this possibility, several tu-
mor promoters have been tested by us and others (9).
Tumor promoters from the series of teleocidin, lyng-
byatoxin, and aplysiatoxin isolated fromLyngbyamajus-
cula or Streptomyces mediocidicus in Sugimura's labo-
ratory (18), have been revealed as potent activators of
protein kinase C and compete on the phorbol esterbind-
ingsite. Inaddition, unsaturated fattyacids, retinoic acid,
and lipoxin A are able to activate invitro protein kinase
C; this reaction does not require phospholipid. Interest-
ingly, unsaturated fatty acids also enhance enzyme activ-
ity in intact platelets(unpublished results). Aspreviously
mentioned, solutions ofthe bile salt sodium deoxycholate
potently activated the enzyme without any requirement
for phospholipid. Likewise, chloroform and other
chlorine-substituted methane derivatives activate protein
kinase C in vitro and in platelets. These drugs did not
compete forthephorbol esterbindingsiteandthe invitro
reactionrequires phospholipid although it was not depen-
dent on Ca +. Thus, chloroform and its derivatives most
likely act in a benzene-like fashion on phospholipid-
enzyme interaction.
In summary, several tumorpromoters can activate pro-
tein kinase C, presumably through interactions at differ-
ent sites ofthe molecule. In contrast, well-characterized
tumor promoters such as anthralin, tetrachlorodibenzodi-
oxin, phenobarbital, palytoxin, benzoyl peroxyde, and
1,25-dihydroxyvitamin D3 do not directly activate the en-
zyme. However, the possibility that these tumor
promoters act downstream from protein kinase C or
through the Ca2+ branch ofthe IP3/DG pathway is cur-
rently under investigation.
Discussion and Conclusion
The present results provide evidence that benzene and
toluene activate inplatelets, as well as in the in vitro as-
say, protein kinase C alone, or in the presence of phor-
bol esterTPA. The site ofaction ofthese organic solvents
on the enzyme are presumably different. What is the
physiological relevance of these findings? Is benzene-
mediatedprotein kinase C activation relevant in its effect
on malignancy?
The effects ofbenzene-on cellproliferation were tested
on the fibroblastic cell line Balb/c-3T3. Preliminary
results have shown an initial marked increase of 3H-
thymidine incorporation into DNA, up to 0.25%, followed
by inhibition ofgrowth at higher concentrations. Phor-
bol esterTPA atlow doses has similar effects onthis cell
line, suggesting that benzene may similarly affect the
IP3/DG pathway.
The concentrations used in ourexperiments aregener-
ally higher than the low daily doses used in experimen-
tal carcinogenesis. However, it should be stressed that
the real amount ofbenzene intervening under our condi-
tions is much less, since most of the added benzene is
bound to the tube or the dish walls.
Takingphorbol ester-mediatedprotein kinase C activa-
tion as a model, by analogy it is hypothesized that ben-
zene may trigger an enzyme activation qualitatively dis-
tinct from that mediated by physiological stimuli. As
reviewed by Hunter (19), the site of action of oncogene
proteins is probably associated with signalingpathways
and most likely with the IP3/DG pathway. It is highly
probable that the elucidation of how oncogene proteins
and tumor promoters cooperate in signal transduction
will considerably help to understand how a cell
progresses to transformation.
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